Market Overview

Ascendis Pharma Reports FY16 EPS €(2.58) vs €(1.39) in FY15, Sales €4.606M

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings

 

Related Articles (ASND)

Partner Center